loadpatents
name:-0.041731119155884
name:-0.025954008102417
name:-0.011291027069092
Riley; James L. Patent Filings

Riley; James L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Riley; James L..The latest application filed is for "a bw6 specific car designed to protect transplanted tissue from rejection".

Company Profile
11.25.34
  • Riley; James L. - Downingtown PA
  • Riley; James L. - Elkridge MD
  • Riley; James L. - Winter Park FL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
A BW6 Specific CAR Designed To Protect Transplanted Tissue From Rejection
App 20220088071 - Riley; James L. ;   et al.
2022-03-24
Non-Signaling HIV Fusion Inhibitors And Methods Of Use Thereof
App 20210338731 - Riley; James L. ;   et al.
2021-11-04
Inducible Regulatory T-cell Generation For Hematopoietic Transplants
App 20210275650 - Riley; James L. ;   et al.
2021-09-09
Use Of Pdl1 Expressing Cells To Convert T Cells Into Regulatory T Cells
App 20210277356 - Riley; James L. ;   et al.
2021-09-09
ICOS critically regulates the expansion and function of inflammatory human Th17 cells
Grant 11,001,805 - Riley , et al. May 11, 2
2021-05-11
Inducible regulatory t-cell generation for hematopoietic transplants
Grant 10,874,727 - Riley , et al. December 29, 2
2020-12-29
Dual Car Expressing T Cells Individually Linked To Cd28 And 4-1bb
App 20200384029 - Riley; James L. ;   et al.
2020-12-10
Method of Redirecting T Cells to Treat HIV Infection
App 20200362012 - Riley; James L. ;   et al.
2020-11-19
Use of PDL1 expressing cells to convert T cells into regulatory T cells
Grant 10,808,225 - Riley , et al. October 20, 2
2020-10-20
Methods to Expand a T Regulatory Cell Master Cell Bank
App 20200263131 - Riley; James L. ;   et al.
2020-08-20
Method of redirecting T cells to treat HIV infection
Grant 10,738,099 - Riley , et al. A
2020-08-11
Expansion Of Populations Of T Cells By The Use Of Modified Serum Free Media
App 20190367874 - Varela-Rohena; Angel M. ;   et al.
2019-12-05
Activation and Expansion of T-Cells Using an Engineered Multivalent Signaling Platform as a Research Tool
App 20190177692 - June; Carl H. ;   et al.
2019-06-13
Artificial antigen presenting cells and uses thereof
Grant 10,286,066 - Riley , et al.
2019-05-14
Inducible Regulatory T-cell Generation For Hematopoietic Transplants
App 20190022199 - Riley; James L. ;   et al.
2019-01-24
ICOS Critically Regulates the Expansion and Function of Inflammatory Human Th17 Cells
App 20180371414 - Riley; James L. ;   et al.
2018-12-27
Methods To Protect Transplanted Tissue From Rejection
App 20180282416 - Riley; James L. ;   et al.
2018-10-04
Method of Redirecting T Cells to Treat HIV Infection
App 20180265565 - Riley; James L. ;   et al.
2018-09-20
ICOS critically regulates the expansion and function of inflammatory human Th17 cells
Grant 9,994,818 - Riley , et al. June 12, 2
2018-06-12
Novel Artificial Antigen Presenting Cells and Uses Thereof
App 20170319684 - Riley; James L. ;   et al.
2017-11-09
Use Of Pdl1 Expressing Cells To Convert T Cells Into Regulatory T Cells
App 20170211042 - Riley; James L. ;   et al.
2017-07-27
Use of PDL1 expressing cells to convert T cells into regulatory T cells
Grant 9,644,179 - Riley , et al. May 9, 2
2017-05-09
Artificial antigen presenting cells and uses thereof
Grant 9,555,105 - Riley , et al. January 31, 2
2017-01-31
Activation and Expansion of T-Cells Using an Engineered Multivalent Signaling Platform as a Research Tool
App 20160348072 - June; Carl H. ;   et al.
2016-12-01
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
Grant 9,453,199 - June , et al. September 27, 2
2016-09-27
Anaplastic Lymphoma Kinase (ALK) As An Oncogene Capable Of Transforming Normal Human Cells
App 20160194616 - Wasik; Mariusz ;   et al.
2016-07-07
Inducible Regulatory T-cell Generation For Hematopoietic Transplants
App 20160151471 - Riley; James L. ;   et al.
2016-06-02
Anaplastic lymphoma kinase (ALK) as an oncogene capable of transforming normal human cells
Grant 9,255,279 - Wasik , et al. February 9, 2
2016-02-09
Inducible regulatory T-cell generation for hematopoietic transplants
Grant 9,228,172 - Riley , et al. January 5, 2
2016-01-05
ICOS Critically Regulates the Expansion and Function of Inflammatory Human Th17 Cells
App 20150342994 - Riley; James L. ;   et al.
2015-12-03
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses
Grant 9,181,526 - Blazar , et al. November 10, 2
2015-11-10
ICOS critically regulates the expansion and function of inflammatory human Th17 cells
Grant 9,133,436 - Riley , et al. September 15, 2
2015-09-15
Anaplastic Lymphoma Kinase (ALK) As An Oncogene Capable Of Transforming Normal Human Cells
App 20150031856 - Wasik; Mariusz ;   et al.
2015-01-29
Use Of Pdl1 Expressing Cells To Convert T Cells Into Regulatory T Cells
App 20140341933 - Riley; James L. ;   et al.
2014-11-20
Novel Artificial Antigen Presenting Cells and Uses Thereof
App 20140212446 - Riley; James L. ;   et al.
2014-07-31
Activation and Expansion of T-Cells Using an Engineered Multivalent Signaling Platform as a Research Tool
App 20140186947 - June; Carl H. ;   et al.
2014-07-03
Artificial antigen presenting cells and uses therefor
Grant 8,722,400 - Riley , et al. May 13, 2
2014-05-13
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
Grant 8,637,307 - June , et al. January 28, 2
2014-01-28
Methods to Expand a T Regulatory Cell Master Cell Bank
App 20130101567 - Riley; James L. ;   et al.
2013-04-25
ICOS Critically Regulates the Expansion and Function of Inflammatory Human Th17 Cells
App 20130071409 - Riley; James L. ;   et al.
2013-03-21
Regulatory T Cells and Their Use in Immunotherapy and Suppression of Autoimmune Responses
App 20120207727 - Blazar; Bruce ;   et al.
2012-08-16
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses
Grant 8,129,185 - Blazar , et al. March 6, 2
2012-03-06
Inducible Regulatory T-Cell Generation for Hematopoietic Transplants
App 20110268752 - Riley; James L. ;   et al.
2011-11-03
Novel Artificial Antigen Presenting Cells and Uses Therefor
App 20110262467 - Riley; James L. ;   et al.
2011-10-27
Methods for downregulating CCR5 in T cells with anti-CD3 antibodies and anti-CD28 antibodies
Grant 7,927,595 - June , et al. April 19, 2
2011-04-19
Regulatory T Cells and Their Use in Immunotherapy and Suppression of Autoimmune Responses
App 20100291678 - Blazar; Bruce ;   et al.
2010-11-18
Artificial antigen presenting cells and uses therefor
Grant 7,754,482 - Riley , et al. July 13, 2
2010-07-13
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses
Grant 7,651,855 - Blazar , et al. January 26, 2
2010-01-26
Methods for modulating expression of an HIV-1 fusion cofactor
App 20060204500 - June; Carl H. ;   et al.
2006-09-14
Novel artificial antigen presenting cells and uses therefor
App 20060034810 - Riley; James L. ;   et al.
2006-02-16
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses
App 20050196386 - Blazar, Bruce ;   et al.
2005-09-08
Apparatus and method for total intravenous anesthesia delivery and associated patient monitoring
Grant 6,186,977 - Andrews , et al. February 13, 2
2001-02-13
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed